Discover PAVmed Inc.'s Q4 2024 earnings highlights, including Lucid Diagnostics' 45% test growth, Veris Health advancements, and strategic milestones.

Recent innovations in evidence based medicine methods, in particular instruments assessing risk of bias in randomised trials, have focused on methodological rigour at the expense of simplicity and ...